JPRN-UMIN000043299已完成未知
An ancillary biomarker study of Gio-Tag Japan. - An ancillary biomarker study of Gio-Tag Japan.
HANSHIN Oncology Group0 个研究点目标入组 93 人开始时间: 2021年2月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 93
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with no residual specimens collected in the main study (Gio-tag Japan) Patients whose data was rejected in the main study
研究者
相似试验
招募中
不适用
Biomarker study of immunological response in Japanese patients with stage III non-small cell lung cancer receiving chemoradiotherapy followed by durvalumabon-small cell lung cancerJPRN-UMIN000039167Wakayama Medical University150
招募中
不适用
Japanese Longitudinal Biomarker Study in PSP and CBDprogressive supranuclear palsy (PSP), corticobasal degeneration (CBD), corticobasal syndrome (CBS)JPRN-UMIN000018468iigata University, Brain Research Institute150
招募中
不适用
Japanese observational study to evaluate the accuracy of preoperative imaging diagnosis for lateral pelvic lymph node metastasis in rectal cancer (JCOG1410-A, JUPITER study)Rectal cancer with rectal resection and lateral pelvic lymph node dissectionJPRN-UMIN000016909Japan Clinical Oncology Group (JCOG)550
招募中
不适用
Retrospective study of prognostic factors for Japanese patients with pulmonary hypertensiopulmonary hypertensionJPRN-UMIN000023819agoya University Graduate School of Medicine300
招募中
3 期
JCOG1502C: Japanese trial -A Global Study To Evaluate The Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinomasmall bowel adenocarcinomaJPRN-jRCTs031180008KANEMITSU Yukihide115